Multiple bidding for low-cost drugs, scale generic pharmaceutical enterprises or take the lead

Source: great wisdom ashdak news agency November 7, 2013 This week, Hunan Provincial Drug collection center issued a draft for direct online directory, including nearly 300 kinds of cheap generic drugs such as vitamin B1, sodium chloride, shark liver alcohol, etc According to the provisions of the internal discussion draft of the provincial bidding document, these drugs do not need to bid after passing the qualification examination in the next bidding, and the unified price is directly linked to the Internet In fact, it is the policy protection for the varieties in the aforesaid catalogue A person from the policy Affairs Department of a listed company told the big smart news agency that after the drugs of some large-scale enterprises enter the catalogue, their prices are better protected, and hospitals tend to use the varieties of these drug enterprises, "which is good for large-scale enterprises" In fact, Hunan is not the first province to give preferential policies to low-cost drugs Many provinces that have published bidding documents will conduct separate bidding for low-cost or low-cost drugs Among them, the Guangdong drug exchange model, which is highly controversial in the industry, is also "tolerant" to low-cost drugs, continuing in 2011 The catalogue of low-cost drugs, which was established in, stipulates that as long as the manufacturers that pass the economic and technical bid and meet the market price can win the bid; Shandong will also include low-cost drugs in a separate procurement catalogue; and Shanxi Province, which is preparing a bidding scheme, is also considering making a separate catalogue of low-cost drugs for separate bidding In fact, the "counter attack" of low-cost drugs is not only included in the consideration of local bidding documents, but also the central government has begun to gradually incline policies to these drugs Recently, the national development and Reform Commission (NDRC) is preparing a list of low-cost drugs, trying to cancel the original maximum retail price, and change it to within the range of daily use costs, so that enterprises can set their own prices The top-down policy dividend has become the "Gospel" of low-cost drugs Domestic large-scale generic pharmaceutical enterprises began to take strategies to seek market share in low-cost drugs Another person in charge of bidding for pharmaceutical companies said that in the Guangdong bidding, some generic drugs of the company "decided to win the bid in low-cost drugs" to avoid price fighting.